Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-11
DOI
10.1038/s41598-020-61510-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
- (2019) Jacopo Baglieri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Contributions of Fibroblasts, Extracellular Matrix, Stiffness, and Mechanosensing to Hepatocarcinogenesis
- (2019) Aveline Filliol et al. SEMINARS IN LIVER DISEASE
- FGF19–FGFR4 Signaling in Hepatocellular Carcinoma
- (2019) Aroosha Raja et al. Cells
- Future applications of FGF/FGFR inhibitors in cancer
- (2018) Gaia Cristina Ghedini et al. Expert Review of Anticancer Therapy
- Infigratinib mediates vascular normalization, impairs metastasis and improves chemotherapy in hepatocellular carcinoma
- (2018) Hung Huynh et al. HEPATOLOGY
- Fibroblast Growth Factor Receptor 4 (FGFR4) Selective Inhibitors as Hepatocellular Carcinoma Therapy: Advances and Prospects
- (2018) Xiaoyun Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Regorafenib reverses HGF-induced sorafenib resistance by inhibiting epithelial-mesenchymal transition in hepatocellular carcinoma
- (2018) Weibo Chen et al. FEBS Open Bio
- Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma
- (2017) Alexander Gerbes et al. GUT
- Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance
- (2017) Peter Dietrich et al. GUT
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option
- (2017) Peter Dietrich et al. Oncotarget
- Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines
- (2017) Yuki Haga et al. PLoS One
- FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
- (2016) MASARU KATOH INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma: Preliminary Clinical Evidence
- (2016) Wei Chen et al. Scientific Reports
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cells
- (2015) Chao Sun et al. BMC CANCER
- Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?
- (2015) Jakob Paur et al. HEPATOLOGY
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening
- (2014) Thuy V. Nguyen et al. BIOMATERIALS
- Tg(Grm1) transgenic mice: A murine model that mimics spontaneous uveal melanoma in humans?
- (2014) Susanne Schiffner et al. EXPERIMENTAL EYE RESEARCH
- MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma
- (2013) Hao Yang et al. HEPATOLOGY
- Fibroblast growth factor signaling in liver carcinogenesis
- (2013) Dalbir S. Sandhu et al. HEPATOLOGY
- SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
- (2013) Raul Aguirre-Gamboa et al. PLoS One
- Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma
- (2012) S Hagiwara et al. BRITISH JOURNAL OF CANCER
- The Significance of Fibroblast Growth Factor Receptor 2 Expression in Differentiation of Hepatocellular Carcinoma
- (2010) Norifumi Harimoto et al. ONCOLOGY
- Mitogen-activated protein kinases in hepatocellular carcinoma development
- (2010) Lihua Min et al. SEMINARS IN CANCER BIOLOGY
- Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma
- (2009) Thomas Amann et al. CANCER SCIENCE
- Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells
- (2009) Hella Wobser et al. CELL RESEARCH
- FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis
- (2008) D J Mulder et al. GUT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search